IPSEN (IPN.PA) Stock Fundamental Analysis
EPA:IPN - Euronext Paris - Matif - FR0010259150 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to IPN. IPN was compared to 52 industry peers in the Pharmaceuticals industry. IPN has only an average score on both its financial health and profitability. IPN has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
IPN had positive earnings in the past year.
In the past year IPN had a positive cash flow from operations.
IPN had positive earnings in each of the past 5 years.
Each year in the past 5 years IPN had a positive operating cash flow.
1.2 Ratios
IPN has a Return On Assets (5.37%) which is in line with its industry peers.
With a Return On Equity value of 8.27%, IPN perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
IPN has a better Return On Invested Capital (13.22%) than 67.31% of its industry peers.
IPN had an Average Return On Invested Capital over the past 3 years of 12.97%. This is in line with the industry average of 14.50%.
The last Return On Invested Capital (13.22%) for IPN is above the 3 year average (12.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.37% | ||
| ROE | 8.27% | ||
| ROIC | 13.22% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
IPN's Profit Margin of 9.68% is in line compared to the rest of the industry. IPN outperforms 44.23% of its industry peers.
IPN's Profit Margin has declined in the last couple of years.
IPN's Operating Margin of 22.15% is in line compared to the rest of the industry. IPN outperforms 57.69% of its industry peers.
In the last couple of years the Operating Margin of IPN has declined.
IPN's Gross Margin of 82.69% is amongst the best of the industry. IPN outperforms 86.54% of its industry peers.
IPN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.15% | ||
| PM (TTM) | 9.68% | ||
| GM | 82.69% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IPN is still creating some value.
Compared to 1 year ago, IPN has more shares outstanding
The number of shares outstanding for IPN remains at a similar level compared to 5 years ago.
IPN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.28 indicates that IPN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.28, IPN is in the better half of the industry, outperforming 71.15% of the companies in the same industry.
The Debt to FCF ratio of IPN is 3.21, which is a good value as it means it would take IPN, 3.21 years of fcf income to pay off all of its debts.
IPN's Debt to FCF ratio of 3.21 is fine compared to the rest of the industry. IPN outperforms 67.31% of its industry peers.
IPN has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
IPN has a Debt to Equity ratio of 0.09. This is in the better half of the industry: IPN outperforms 78.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 3.21 | ||
| Altman-Z | 4.28 |
ROIC/WACC1.74
WACC7.59%
2.3 Liquidity
A Current Ratio of 1.34 indicates that IPN should not have too much problems paying its short term obligations.
IPN has a Current ratio (1.34) which is in line with its industry peers.
IPN has a Quick Ratio of 1.15. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.15, IPN is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.34 | ||
| Quick Ratio | 1.15 |
3. Growth
3.1 Past
IPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
The Earnings Per Share has been growing by 8.79% on average over the past years. This is quite good.
IPN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.11%.
The Revenue has been growing slightly by 5.83% on average over the past years.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%24.21%
Revenue 1Y (TTM)8.11%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%8.28%
3.2 Future
Based on estimates for the next years, IPN will show a small growth in Earnings Per Share. The EPS will grow by 4.81% on average per year.
IPN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.54% yearly.
EPS Next Y1.78%
EPS Next 2Y4.08%
EPS Next 3Y5.64%
EPS Next 5Y4.81%
Revenue Next Year6.73%
Revenue Next 2Y5.94%
Revenue Next 3Y6.33%
Revenue Next 5Y4.54%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 10.29 indicates a reasonable valuation of IPN.
Compared to the rest of the industry, the Price/Earnings ratio of IPN indicates a rather cheap valuation: IPN is cheaper than 82.69% of the companies listed in the same industry.
IPN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 10.11 indicates a reasonable valuation of IPN.
Based on the Price/Forward Earnings ratio, IPN is valued a bit cheaper than the industry average as 73.08% of the companies are valued more expensively.
IPN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.76.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.29 | ||
| Fwd PE | 10.11 |
4.2 Price Multiples
90.38% of the companies in the same industry are more expensive than IPN, based on the Enterprise Value to EBITDA ratio.
IPN's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. IPN is more expensive than 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 66.61 | ||
| EV/EBITDA | 5.74 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IPN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of IPN may justify a higher PE ratio.
PEG (NY)5.77
PEG (5Y)1.17
EPS Next 2Y4.08%
EPS Next 3Y5.64%
5. Dividend
5.1 Amount
IPN has a Yearly Dividend Yield of 1.29%.
Compared to an average industry Dividend Yield of 3.00, IPN has a dividend in line with its industry peers.
With a Dividend Yield of 1.29, IPN pays less dividend than the S&P500 average, which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.29% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
28.79% of the earnings are spent on dividend by IPN. This is a low number and sustainable payout ratio.
IPN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.79%
EPS Next 2Y4.08%
EPS Next 3Y5.64%
EPA:IPN (7/11/2025, 7:00:00 PM)
105.7
-2.5 (-2.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners14.53%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap8.86B
Analysts68.42
Price Target127.41 (20.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.29% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP28.79%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.3%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.29 | ||
| Fwd PE | 10.11 | ||
| P/S | 2.48 | ||
| P/FCF | 66.61 | ||
| P/OCF | 9.68 | ||
| P/B | 2.12 | ||
| P/tB | 9.19 | ||
| EV/EBITDA | 5.74 |
EPS(TTM)10.27
EY9.72%
EPS(NY)10.45
Fwd EY9.89%
FCF(TTM)1.59
FCFY1.5%
OCF(TTM)10.92
OCFY10.33%
SpS42.65
BVpS49.89
TBVpS11.5
PEG (NY)5.77
PEG (5Y)1.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.37% | ||
| ROE | 8.27% | ||
| ROCE | 16.05% | ||
| ROIC | 13.22% | ||
| ROICexc | 15.36% | ||
| ROICexgc | 63.33% | ||
| OM | 22.15% | ||
| PM (TTM) | 9.68% | ||
| GM | 82.69% | ||
| FCFM | 3.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexcg growth 3Y-59.92%
ROICexcg growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score6
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 3.21 | ||
| Debt/EBITDA | 0.26 | ||
| Cap/Depr | 110.85% | ||
| Cap/Sales | 21.89% | ||
| Interest Coverage | 96.55 | ||
| Cash Conversion | 61.13% | ||
| Profit Quality | 38.45% | ||
| Current Ratio | 1.34 | ||
| Quick Ratio | 1.15 | ||
| Altman-Z | 4.28 |
F-Score6
WACC7.59%
ROIC/WACC1.74
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%24.21%
EPS Next Y1.78%
EPS Next 2Y4.08%
EPS Next 3Y5.64%
EPS Next 5Y4.81%
Revenue 1Y (TTM)8.11%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%8.28%
Revenue Next Year6.73%
Revenue Next 2Y5.94%
Revenue Next 3Y6.33%
Revenue Next 5Y4.54%
EBIT growth 1Y34.12%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year27.18%
EBIT Next 3Y13.1%
EBIT Next 5Y6.41%
FCF growth 1Y-80.91%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y4.09%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%